Brokerages Anticipate Invacare Co. (NYSE:IVC) to Announce -$0.43 EPS

Wall Street analysts predict that Invacare Co. (NYSE:IVCGet Rating) will announce earnings of ($0.43) per share for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Invacare’s earnings, with the lowest EPS estimate coming in at ($0.44) and the highest estimate coming in at ($0.42). Invacare reported earnings of ($0.36) per share during the same quarter last year, which indicates a negative year-over-year growth rate of 19.4%. The business is expected to issue its next earnings report on Monday, January 1st.

According to Zacks, analysts expect that Invacare will report full year earnings of ($0.77) per share for the current fiscal year, with EPS estimates ranging from ($0.84) to ($0.69). For the next fiscal year, analysts anticipate that the business will report earnings of ($0.38) per share, with EPS estimates ranging from ($0.46) to ($0.30). Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that cover Invacare.

Invacare (NYSE:IVCGet Rating) last announced its earnings results on Tuesday, March 8th. The health services provider reported $0.08 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.02 by $0.06. Invacare had a negative net margin of 5.22% and a negative return on equity of 9.22%. During the same period in the prior year, the firm earned ($0.10) earnings per share.

Separately, StockNews.com began coverage on shares of Invacare in a research report on Thursday, March 31st. They set a “hold” rating on the stock. Two analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $8.50.

In other news, CFO Kathleen P. Leneghan acquired 20,000 shares of Invacare stock in a transaction on Friday, March 11th. The shares were purchased at an average cost of $1.49 per share, for a total transaction of $29,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Matthew E. Monaghan acquired 33,000 shares of Invacare stock in a transaction on Friday, March 11th. The shares were purchased at an average price of $1.49 per share, for a total transaction of $49,170.00. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 63,000 shares of company stock worth $93,870. 6.20% of the stock is owned by insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Walleye Capital LLC acquired a new stake in shares of Invacare in the 4th quarter valued at approximately $329,000. Barclays PLC boosted its stake in shares of Invacare by 49.0% in the 4th quarter. Barclays PLC now owns 40,852 shares of the health services provider’s stock valued at $111,000 after purchasing an additional 13,440 shares in the last quarter. Walleye Trading LLC acquired a new stake in shares of Invacare in the 4th quarter valued at approximately $44,000. Goldman Sachs Group Inc. boosted its stake in shares of Invacare by 160.1% in the 4th quarter. Goldman Sachs Group Inc. now owns 472,745 shares of the health services provider’s stock valued at $1,286,000 after purchasing an additional 290,992 shares in the last quarter. Finally, Parametric Portfolio Associates LLC boosted its stake in shares of Invacare by 13.2% in the 4th quarter. Parametric Portfolio Associates LLC now owns 371,742 shares of the health services provider’s stock valued at $1,011,000 after purchasing an additional 43,483 shares in the last quarter. Institutional investors own 99.25% of the company’s stock.

IVC traded down $0.09 during trading hours on Friday, hitting $1.44. 502,621 shares of the company’s stock were exchanged, compared to its average volume of 754,995. Invacare has a 1-year low of $1.38 and a 1-year high of $9.23. The stock’s 50-day moving average is $1.72 and its two-hundred day moving average is $2.73. The stock has a market cap of $50.48 million, a price-to-earnings ratio of -1.09 and a beta of 1.04. The company has a quick ratio of 0.98, a current ratio of 1.56 and a debt-to-equity ratio of 1.69.

About Invacare (Get Rating)

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand.

Featured Stories

Get a free copy of the Zacks research report on Invacare (IVC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.